EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?

Title: EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?

Volume: 11 Issue: 6

Author(s): Shailender Singh Kanwar, Jyoti Nautiyal and Adhip P.N. Majumdar

Affiliation:

Keywords: EGFR inhibitors, colon cancer, apoptosis

Abstract: In the past 10 to 15 years, a considerable progress has been made in the treatment of gastrointestinal (GI) related malignancies, as a number of agents expanded from only one in 1995 to seven in 2006. Current review describes the recent role of targeted therapies, specifically EGFR inhibitors in the treatment of GI cancers. Importance of dietary agents in the treatment and prevention of GI cancers is also reviewed.

Cite this article as:

Singh Kanwar Shailender, Nautiyal Jyoti and P.N. Majumdar Adhip, EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?, Current Drug Targets 2010; 11 (6) . https://dx.doi.org/10.2174/138945010791170851